283 related articles for article (PubMed ID: 22565901)
1. Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw.
Cicciù M; Herford AS; Juodžbalys G; Stoffella E
J Craniofac Surg; 2012 May; 23(3):784-8. PubMed ID: 22565901
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-related osteonecrosis of the jaws.
Ruggiero SL
Compend Contin Educ Dent; 2008 Mar; 29(2):96-8, 100-2, 104-5. PubMed ID: 18429424
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
Dimitrakopoulos I; Magopoulos C; Karakasis D
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
[TBL] [Abstract][Full Text] [Related]
4. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
5. Osteonecrosis of the jaws and bisphosphonate therapy.
Ruggiero SL; Drew SJ
J Dent Res; 2007 Nov; 86(11):1013-21. PubMed ID: 17959890
[TBL] [Abstract][Full Text] [Related]
6. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients.
Favia G; Pilolli GP; Maiorano E
J Rheumatol; 2009 Dec; 36(12):2780-7. PubMed ID: 19884275
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
Gutta R; Louis PJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates and osteonecrosis of the jaws.
Mariotti A
J Dent Educ; 2008 Aug; 72(8):919-29. PubMed ID: 18676801
[TBL] [Abstract][Full Text] [Related]
10. The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw.
Wilde F; Heufelder M; Winter K; Hendricks J; Frerich B; Schramm A; Hemprich A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Feb; 111(2):153-63. PubMed ID: 20674411
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
12. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
Friedrich RE; Blake FA
Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
[TBL] [Abstract][Full Text] [Related]
13. Treatment results of bisphosphonate-related osteonecrosis of the jaws.
Wutzl A; Biedermann E; Wanschitz F; Seemann R; Klug C; Baumann A; Watzinger F; Schicho K; Ewers R; Millesi G
Head Neck; 2008 Sep; 30(9):1224-30. PubMed ID: 18642292
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis.
Manfredi M; Merigo E; Guidotti R; Meleti M; Vescovi P
Int J Oral Maxillofac Surg; 2011 Mar; 40(3):277-84. PubMed ID: 21163625
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of bisphosphonate induced osteonecrosis of the jaws.
Williamson RA
Int J Oral Maxillofac Surg; 2010 Mar; 39(3):251-5. PubMed ID: 20015614
[TBL] [Abstract][Full Text] [Related]
16. Warning: bisphosphonates and osteochemonecrosis of the jaws.
Flint SR; Sharkey S; Galvin S
J Ir Dent Assoc; 2006; 52(2):79-83. PubMed ID: 16989369
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-induced osteonecrosis of the jaw.
Krueger CD; West PM; Sargent M; Lodolce AE; Pickard AS
Ann Pharmacother; 2007 Feb; 41(2):276-84. PubMed ID: 17299010
[TBL] [Abstract][Full Text] [Related]
18. Jaw osteonecrosis related to bisphosphonate treatment of bone metastasis.
Raffaelli L; Scaramuzzo L; Rossi Iommetti P; Graci C; Maccauro G; Manicone PF
J Biol Regul Homeost Agents; 2010; 24(2):115-21. PubMed ID: 20487624
[TBL] [Abstract][Full Text] [Related]
19. [Surgical treatment of maxillary osteonecrosis due to bisphosphonates using an Er:YAG (2940 nm) laser. Discussion of 17 clinical cases].
Vescovi P; Merigo E; Manfredi M; Meleti M; Fornaini C; Bonanini M; Rocca EP; De Moor RJ; Nammour S
Rev Belge Med Dent (1984); 2009; 64(2):87-95. PubMed ID: 19681350
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report.
Rugani P; Acham S; Truschnegg A; Obermayer-Pietsch B; Jakse N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):e1-6. PubMed ID: 21112522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]